Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bicycle Therapeutics Plc ADR (NQ: BCYC )

15.71 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 15.71
Bid (Size) 15.30 (1)
Ask (Size) 16.25 (1)
Prev. Close 15.71
Today's Range 15.71 - 15.71
52wk Range 12.54 - 33.49
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Bicycle Therapeutics to Host R&D Day on December 14
From Bicycle Therapeutics
Via Business Wire

Performance

YTD
-47.63%
-47.63%
1 Month
+3.02%
+3.02%
3 Month
-24.76%
-24.76%
6 Month
-37.39%
-37.39%
1 Year
-49.52%
-49.52%

More News

Read More
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Expert Ratings for Bicycle Therapeutics
Via Benzinga
Where Bicycle Therapeutics Stands With Analysts
Via Benzinga
Expert Ratings for Bicycle Therapeutics
Via Benzinga
Bicycle Therapeutics's Return On Capital Employed Insights
Via Benzinga
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer
From Bicycle Therapeutics
Via Business Wire
Bicycle Therapeutics PLC (NASDAQ: BCYC) Making Surprising Moves in Friday Session
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
Via Benzinga
Why Shares of Bicycle Therapeutics Were Rising on Monday
Via The Motley Fool
Exposures Product Safety
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
From Bicycle Therapeutics
Via Business Wire
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Bicycle Therapeutics
Via Business Wire
Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Bicycle Therapeutics plc
Via Business Wire
Why Bicycle Therapeutics Stock Raced Ahead Today
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit
From Bicycle Therapeutics plc
Via Business Wire
Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference
From Bicycle Therapeutics plc
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.